Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-32,718
Closed -$1.57M 4648
2025
Q4
$1.57M Buy
32,718
+11,829
+57% +$538K 0.01% 1447
2025
Q3
$923K Buy
+20,889
New +$968K ﹤0.01% 1563
2025
Q2
Sell
-38,929
Closed -$2.61M 3444
2025
Q1
$2.61M Buy
38,929
+23,019
+145% +$1.68M 0.02% 694
2024
Q4
$1.26M Buy
+15,910
New +$1.37M 0.01% 960
2024
Q1
Sell
-38,755
Closed -$1.9M 3029
2023
Q4
$1.9M Buy
+38,755
New +$1.81M 0.01% 671
2023
Q2
Sell
-45,742
Closed -$2.12M 3208
2023
Q1
$2.12M Buy
+45,742
New +$2.17M 0.03% 560
2022
Q4
Sell
-71,677
Closed -$2.43M 3074
2022
Q3
$2.43M Buy
+71,677
New +$2.72M 0.03% 535
2022
Q2
Sell
-35,443
Closed -$1.18M 3662
2022
Q1
$1.18M Buy
35,443
+17,429
+97% +$578K 0.01% 920
2021
Q4
$502K Buy
+18,014
New +$525K ﹤0.01% 1764

Other funds holding SLVM

HRT Financial's SLVM Position: Q1 2026 in Review

HRT Financial sold out of Sylvamo (SLVM) in Q1 2026, closing a stake of 32,718 shares — an estimated $1.57M sold.

HRT Financial first reported a position in SLVM in Q4 2021 and held it in 9 quarters. The position peaked at $2.61M in Q1 2025. 320 funds tracked by Wall St. Rank hold SLVM as of Q1 2026.

  • HRT Financial reported no remaining Sylvamo position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 32,718 Sylvamo shares in Q1 2026, an estimated $1.57M.
  • HRT Financial first reported a position in Sylvamo in Q4 2021 and held it in 9 quarters.
  • HRT Financial's Sylvamo position peaked at $2.61M in Q1 2025.
  • 320 funds tracked by Wall St. Rank held Sylvamo as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.